MentionFox
Home › Stakes › Matinas BioPharma Holdings, Inc.
5%+ stakes · Schedule 13D and 13G

Matinas BioPharma Holdings, Inc.: 5%+ holders

Who has reported owning 5% or more of Matinas BioPharma Holdings, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more3
Filings6
Latest filing2026-08-13

Matinas BioPharma Holdings, Inc. has 6 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Sanitam Partners LLC9.99%0SCHEDULE 13D/A, 2026-08-132026-06-10
Lazar David E.9.81%545,000SCHEDULE 13G, 2025-08-192025-08-15
Hezbay Holdings LLC9.54%1,306,488SCHEDULE 13G, 2026-07-142026-07-13
Highbridge Capital Management, LLC0%0SCHEDULE 13G/A, 2025-11-142025-09-30

Purpose of Transaction (Item 4)

Sanitam Partners LLC

Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following: The Reporting Persons' response to Item 5(c) is incorporated by reference into this Item 4.Item 4 of the SCHEDULE 13D/A filed 2026-08-13

Timeline

FiledHolderPercentFiling
2025-08-14Highbridge Capital Management, LLC8.4%SCHEDULE 13G/A
2025-08-19Lazar David E.9.81%SCHEDULE 13G
2025-09-25Hezbay Holdings LLC4.99%SCHEDULE 13D/A
2025-11-14Highbridge Capital Management, LLC0%SCHEDULE 13G/A
2026-07-14Hezbay Holdings LLC9.54%SCHEDULE 13G
2026-08-13Sanitam Partners LLC9.99%SCHEDULE 13D/A

Tools for this story

Each opens in a new tab, filled in for Matinas BioPharma Holdings, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/matinas-biopharma-holdings
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Matinas BioPharma Holdings, Inc. 5%+ holders: 3 at 5% or more, largest Sanitam Partners LLC 9.99%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/matinas-biopharma-holdings